ILP-2 (N-Term) Peptide

Details for Product No. ABIN1382114
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Protein Name
Synonyms ILP-2, ILP2, hILP2
Protein Region
N-Term
Origin
Human
(1)
Application
Blocking Peptide (BP)
Pubmed 3 references available
Quantity 0.05 mg
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN1382114
77.00 $
Plus shipping costs $45.00

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics 12 amino amino terminus of human ILP-2.
Human
Research Area Apoptosis/Necrosis
Application Notes ILP-2 peptide is used for blocking the. activity of ILP-2.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Hugot, Chamaillard, Zouali et al.: "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 599-603, 2001 (PubMed).

Ogura, Bonen, Inohara et al.: "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 603-6, 2001 (PubMed).

Richter, Mir, Eiben et al.: "Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family." in: Molecular and cellular biology, Vol. 21, Issue 13, pp. 4292-301, 2001 (PubMed).

Validation Images
back to top